We are on a Mission to Improve care with AI
SALUS is HACARUS’ platform for Medical & Life Sciences AI solutions. We work with Medical imaging data such as CT & MRI scans, time series data, such as ECG data, and medical record to create precise, complex tools, that aid care givers and researchers to provide better, faster and safer treatment, based on data driven insights.
Medical Case Studies
AI Enabled Cerebral Infarction Diagnosis Assistance – HACARUS & Ohara Pharmaceutical
Highly specialized MRI image interpretation technology is required to diagnose cerebral infarction, and accurate treatment type selection is required to select a treatment method. In particular, the treatment of acute cerebral infarction is time-consuming and requires prompt diagnosis and treatment. There are many hospitals that do not have a cerebral infarction specialist even though they have MRI imaging equipment.
To tackle this issue, HACARUS and OHARA Pharmaceutical Co.,Ltd. are working together with a leading Medical University to digitize specialists’ knowledge, aiming to offer AI enabled assistance in acute cerebral infarction diagnosis. By combining data from MRI and other vital patient data, our model is able to accurately aid doctors. Digitalization of expert knowledge will also further reduce the risks of late diagnosis, and importantly loosen the strain on specialists. In addition, it enables rapid diagnosis and appropriate treatment of cerebral infarction even in hospitals without specialists.
Joint research for Liver Cancer diagnosis support tool
A current shortage of specialists possessing the required knowledge to interpret the scans means that the healthcare system is increasingly unable to meet a growing demand for diagnosis. Therefore HACARUS and Kobe University will conduct joint research aiming to:
(1) Detect risk areas in MRI images using AI trained by using supervised learning. (2) Perform HCC disease type classification in risk areas. (3) Create an accurate AI type classification and diagnosis support system.
AI support system for prevention and early diagnosis of cervical cancer
HACARUS and Kyoto University aim to digitize specialist oncologist’s know-how and during the joint R&D project the two parties will: Build a highly accurate AI model for early cancer detection using colposcopy video data, enable AI fueled diagnosis support in line with the diagnosis and treatment standards of Japan and construct a tool that can identify lesions with high accuracy and assist diagnosis of tissue sampling in facilities where specialists are not present.
The results will be presented in academic papers, and at related conferences, as well as exhibited at trade-shows.
AI based anomaly detection in ECG signals – Solution development with ITK Engineering
The German technology company ITK Engineering – a subsidiary of Bosch – and Hacarus have jointly developed a proof of concept for a personalized patient monitoring system, serving to evaluate ECG signals. It not only evaluates anomalies in a single patient heart’s ECG in near real-time, but also provides at-a-glance comparisons with the expected normal ECG curve.
Partnership with DS Pharma Animal Health
DS Pharma Animal Health and Hacarus are developing a non-intrusive ECG measurement and analytics tool for animals, based on a connected sheet that has the ability to capture vital heart data from standing animals paws. The sheet is connected to an edge base station, which includes the AI software by Hacarus, which then communicates with a cloud platform (あにさぽ®) for veterinarians provided by DS Pharma Animal Health.
Life Sciences Use Cases
Using HACARUS AI expertise we can assist in tasks such as the identification, measurement or comparison of genomic features including DNA sequence, structural variation, gene expression, or regulatory and functional element annotation at a genomic scale.
Fueled by HACARUS AI algorithms we can aid in developing methods to regrow, repair or replace damaged or diseased cells, organs or tissues. Including the generation and use of therapeutic stem cells, tissue engineering and the production of artificial organs.
AI-Assisted Drug Discovery
With HACARUS built AI tools we can simplify drug discovery, using machine learning techniques focused on pattern recognition, material informatics and data modeling.
Benefits of Hacarus AI
Hacarus AI understands patient data the way doctors and medical professionals do – by identifying the key symptoms and features of a condition. This human centric approach delivers a series of advantages: